A retrospective analysis was performed on thoracic ESCC patients who received surgery in Tangdu Hospital affiliated to Fourth Military Medical University from April 2019 to December 2020. The 8th version of American Joint Committee on Cancer was used for preoperative and postoperative staging of the patients.[11 (link)] Inclusion criteria as follows: Thoracic ESCC received Mckeown resection; Lymph node dissection ≥ 2.0 field; Preoperative albumin-binding paclitaxel combined with nedaplatin chemotherapy for 2 to 3 cycles, and; Postoperative TRG analysis was performed.
Free full text: Click here